All I can say is that they have surprised a few experienced (current and past) holders in their recent quarterlies... agree with others that the ongoing CIV-19 situation and realization of many that the vaccine will not just make CIV-19 disappear will make MP1's offering to continue to be relevant
Now MP1 has to keep delivering to match their pricing... whereas previously it was their pricing catching up with their potential
Is MP1 less revelant, now that vaccines are coming., page-20
Add MP1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$8.94 |
Change
-0.380(4.08%) |
Mkt cap ! $1.425B | |||
| Open | High | Low | Value | Volume |
| $8.80 | $9.16 | $8.51 | $49.26M | 5.530M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 112 | $8.93 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $8.98 | 438 | 1 |
View Market Depth
| Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
| MP1 (ASX) Chart |